피부과용 영상 기기 시장 : 양식, 용도, 최종 사용자별, 세계 예측(2024-2032년)

Global Dermatology Imaging Devices Market size will expand at a 12.7% CAGR from 2024 to 2032, owing to continuous innovation in imaging technologies coupled with the rise of telemedicine and remote patient monitoring. Advanced imaging technologies offer enhanced accuracy and efficiency in diagnosing skin conditions, while the increasing adoption of telemedicine facilitates remote consultations and screenings. As healthcare providers seek more accessible and efficient solutions for dermatological assessments, the demand for sophisticated imaging devices suitable for telemedicine applications will surge, fueling market expansion.

For instance, in June 2023, DeepX Diagnostics obtained FDA clearance for their digital dermatoscope, DermoSight, facilitating teledermatology screening of potential skin cancer lesions in the US. It indicates growing acceptance and adoption of teledermatology solutions, enhancing accessibility and efficiency in diagnosing potential skin cancer lesions. This development also underscores the importance of regulatory approval in driving innovation and market expansion. As teledermatology gains traction, there's potential for increased demand for similar imaging devices worldwide, driving growth in the global dermatology imaging devices industry.

The dermatology imaging devices market is fragmented based on modality, application, end user, and region.

The inflammatory dermatoses segment will see a considerable surge by 2032, driven by the growing prevalence of inflammatory skin conditions worldwide. Dermatology imaging devices play a crucial role in diagnosing and monitoring inflammatory dermatoses, such as psoriasis and eczema, by providing detailed visualizations of skin lesions and underlying structures. Additionally, advancements in imaging technologies, coupled with rising awareness about early disease detection and treatment, further drive the demand for dermatology imaging devices in this segment.

The dermatology centers segment will garner substantial gains through 2032, attributed to the central role these facilities play in diagnosing and treating various skin conditions. With increasing demand for accurate and efficient diagnostic tools, dermatology centers invest in advanced imaging devices to enhance patient care. Moreover, the rising prevalence of skin disorders and the growing popularity of cosmetic dermatology procedures further drive the demand for imaging technologies in these centers, solidifying their dominance in the market.

Asia Pacific dermatology imaging devices industry share will experience a notable CAGR between 2024 and 2032 due to rising incidences of skin disorders, increasing healthcare expenditure, and advancements in medical technology. The region's growing aging population and heightened awareness about early diagnosis and treatment of skin conditions further fuel market demand. Additionally, expanding healthcare infrastructure and the presence of key market players in countries like China and India solidify Asia Pacific's position as a primary contributor to the dermatology imaging devices market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Enhanced awareness and timely identification of dermatological issues
    • 3.2.1.2 Continuous advancements in dermatology imaging technologies
    • 3.2.1.3 Increasing incidence of skin cancer worldwide
    • 3.2.1.4 Growing focus on non-invasive diagnostic techniques in dermatology
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of devices
    • 3.2.2.2 Lack of standardization in dermatology imaging protocols
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Million)

• 5.1 Key trends
• 5.2 Dermatoscope
• 5.3 Optical coherence tomography
• 5.4 Digital photographic imaging
• 5.5 High frequency ultrasound
• 5.6 Other modalities

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Million)

• 6.1 Key trends
• 6.2 Skin cancers
• 6.3 Inflammatory dermatoses
  • 6.3.1 Skin psoriasis
  • 6.3.2 Atopic dermatitis
  • 6.3.3 Other inflammatory dermatoses
• 6.4 Plastic and reconstructive surgery
• 6.5 Burn management
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End User, 2021 - 2032 ($ Million)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Dermatology centers
• 7.4 Specialty clinics

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Canfield Scientific, Inc.
• 9.2 Fotofinder Systems GmbH
• 9.3 e-con Systems Inc.
• 9.4 Courage+Khazaka Electronic GmbH
• 9.5 Longport, Inc.
• 9.6 Cortex Technology
• 9.7 Draminski S.A.
• 9.8 GE Healthcare Technologies, Inc.
• 9.9 VisualSonics
• 9.10 Clarius
• 9.11 Koninklijke Philips N.V.
• 9.12 Michelson Diagnostics Ltd.
• 9.13 Caliber Imaging and Diagnosis
• 9.14 DermLite
• 9.15 DermaSensor, Inc.